Sofinnova et al. in €35m series-C round for CorWave
BPI France, Novo Holdings, Seventure Partners, Sofinnova Partners and Ysios Capital have significantly increased their stakes in France-based medical device developer CorWave in a €35m series-C funding round.
Financière Arbevel, Singaporean family office M&L Healthcare, and the European Commission joined as new investors.
The EC deployed €15m in equity via its €3.6bn EIC Fund, marking its first investment from the vehicle.
CorWave, which has so far raised €80m in equity and non-dilutive funding, will use the proceeds to finalise the development of its product, build its manufacturing infrastructure, complete regulatory testing required to conduct human implants, and start its clinical trials.
Company
Founded in 2012 and based in Clichy, CorWave is working on developing cardiac assist devices including a new implantable heart pump. It employs more than 50 staff.
People
CorWave – Louis de Lillers (CEO); Zina Hamoumi (CFO).
Sofinnova Partners – Gérard Hascoët (partner).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









